Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Health And Human Services was posted on May 15, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Illumina MiSeq i100 System

Awarded
75F40126Q22123Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The FDA Office of Acquisition and Grant Services is procuring a single Illumina MiSeq i100 Whole Genome Sequencing System for use at the Irvine Medical Products Laboratory under a sole-source acquisition authorized under FAR Part 12 and FAR 13.106-1(b)(1), as the system is the only one capable of integrating with existing validated laboratory workflows, consumables, sequencing methods, software environments, and operational procedures. The acquisition includes the complete system with control computer, monitor, onboard software, and RFID-based consumable tracking, along with delivery, installation, up to three operator training sessions, and a one-year manufacturer warranty. Delivery is to the FDA/IRVLMP facility in Irvine, CA, under FOB Destination terms, with inspection and final acceptance conducted by the Government at that location. The system must meet strict technical specifications including sequencing-by-synthesis technology, a minimum read length of 2 × 300 bp, output of up to 25 Gb per run, at least 85% Q30 base quality, room-temperature reagent storage, and a benchtop footprint not exceeding 16” × 18” × 26”. The solicitation is evaluated on a Lowest Price Technically Acceptable basis, where offerors must meet all mandatory salient characteristics to be considered technically acceptable, after which the lowest-priced compliant offeror will be selected. No trade-offs between cost and technical performance are permitted. The solicitation number is 75F40126Q22123, with a response deadline of May 22, 2026, and proposals must be submitted via email with required documentation including proof of UEI and SAM.gov registration, firm-fixed pricing for all CLINs, warranty terms, lead time, and country of origin, organized in searchable PDF and Excel formats. Payment must be made exclusively through the Treasury’s Invoice Processing Platform, and contractors must comply with applicable FAR and HHSAR clauses regarding whistleblower rights, cybersecurity safeguarding, trafficking in persons, electronic invoicing, personal identity verification, and other federal compliance requirements. The contract is not set aside for small businesses, though offerors must certify size status under NAICS code 334516, and the Government retains the right to extend services for up to six months if needed.

General Info

Sole-source purchase of Illumina MiSeq i100 system with training and warranty for FDA genomic sequencing.

Contract Value

$53,442.9

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Place of Performance

MD, USA

Set-Aside

NONE

Award Issued Date

Documents

3

RFQ 75F40126Q22123 Whole Genome Sequencing Instrument for IRVLMP

PDF, High priority: read this firstrfq
High

SOW for Whole Genome Sequencing Instrument Purchase OC-2026-132529

PDF, High priority: read this firstsow
High

Justification for Other Than Full and Open Competition for Illumina MiSeq i100 System

PDF, Low priorityjustification-and-authorization
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Solicitation

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts1 person available
OfficeRockville, MD, 20852, USA
Office AddressRockville, MD, 20852, USA

Full Description

Show more

This requirement is for the acquisition of one (1) Illumina MiSeq i100 Whole Genome Sequencing System for the FDA Irvine Medical Products Laboratory (IRVLMP). The procurement is being conducted on a sole-source basis under RFO FAR Part 12 and FAR 13.106-1(b)(1), as the Illumina MiSeq i100 System is the only system determined capable of meeting the Government’s minimum requirements for compatibility with existing validated laboratory workflows, consumables, sequencing methods, software environments, and operational procedures. The requirement includes associated components, software, delivery, installation, training, and manufacturer warranty support.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541611
New
Federal
Contractor-Hosted Fully Integrated Records Facility (FIRF) IDIQ
Solicitation # 75F40126R00009
Solicitation 75F40126R00009 is a request for proposals for a single Indefinite Delivery, Indefinite Quantity (IDIQ) contract to provide Contractor-Hosted Fully Integrated Records Facility (FIRF) services for the FDA. This acquisition is exclusively set aside for Service-Disabled Veteran-Owned Small Business (SDVOSB) concerns under NAICS code 541611. The contract has a maximum ceiling of 50 million dollars with a guaranteed minimum of 10,000 dollars. The anticipated period of performance consists of five 12-month ordering periods from December 1, 2026, through November 30, 2031, with an additional six-month option to extend services through May 31, 2032. The contract will support various task order types, including Time-and-Materials, Labor-Hour, and Firm-Fixed Price. The scope of work requires the contractor to manage an offsite document control facility to standardize records management and transition the agency toward a near 100 percent electronic environment for premarket and postmarket submissions. Key task areas include program management, document processing, scanning, data entry, tracking, temporary storage, and transition activities. Performance will primarily occur at FDA facilities in the Washington, D.C. metropolitan area, specifically within Maryland. Award will be made on a Lowest Price-Technically Acceptable (LPTA) basis, evaluating technical factors and past performance on an acceptable or unacceptable basis. Proposals must be submitted electronically in three separate volumes, with a final submission deadline of November 5, 2026, at 2:00 PM Eastern Time.
Administrative Management and General Management Consulting Services

POSTED

2 days ago

DEADLINE

in 7 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS